Sixty per cent (60%) of patients in the placebo group reached this target blood pressure whereas this figure was 76% and 78% in the irbesartan and amlodipine groups respectively.
60% platseebogrupi patsientidest saavutas sellise soovitud vererõhu väärtuse, kusjuures irbesartaani ja amlodipiini grupis oli see vastavalt 76% ja 78%.